UK markets closed

TC Biopharm (Holdings) Plc (TCBP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.3211-0.0334 (-9.42%)
At close: 03:58PM EST
0.3180 -0.00 (-0.97%)
After hours: 07:55PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,845
3,845
1,979
1,979
3,427
Operating expenses
Research development
7,448
7,448
6,157
6,680
8,614
Selling general and administrative
8,318
8,318
3,109
2,207
3,015
Total operating expenses
15,766
15,766
9,259
8,317
10,067
Operating income or loss
-11,921
-11,921
-7,281
-6,339
-6,641
Interest expense
6,994
6,994
3,439
292.062
275.41
Total other income/expenses net
15,804
15,804
-4,264
-
-
Income before tax
-3,110
-3,110
-14,983
-6,630
-6,894
Income tax expense
-1,720
-1,720
-1,408
-1,172
-826.065
Income from continuing operations
-1,390
-1,390
-13,576
-5,458
-6,068
Net income
-1,390
-1,390
-13,576
-5,458
-6,068
Net income available to common shareholders
-1,390
-1,390
-13,576
-5,458
-6,068
Basic EPS
-2.02
-2.02
-34.73
-9.73
-10.81
Diluted EPS
-2.02
-2.02
-34.73
-9.73
-10.81
Basic average shares
687.199
687.199
390.952
561.167
561.167
Diluted average shares
687.199
687.199
390.952
561.167
561.167